Effect of 4-hydroxynonenal, a product of lipid peroxidation, on natural cell mediated cytotoxicity

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5149-5154

  Tricarico, Maria ^a   Rinaldi, Monica ^a,c   Bonmassar, Enzo ^a,b,e   Fuggetta, Maria Pia ^a   Barrera, Giuseppina ^d   Fazio, Vito Michele ^a,c,f  

^a CNR   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^f IRCCS H Casa Sollievo Della S   (Italy)

Author keywords

HNE; Interferon; Natural immunity; NK; Tumor

Indexed keywords

4 HYDROXYNONENAL; BETA INTERFERON;

ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; TUMOR CELL;

ALDEHYDES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON-BETA; K562 CELLS; KILLER CELLS, NATURAL; LIPID PEROXIDATION;

EID: 0033389114     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Esterbauer H: Aldehydic products of lipid peroxidation. In: Free Radicals, Lipid Peroxidation and Cancer (McBrien D.H.C. and Slater T.F. eds). Academic press, pp 101-125, 1982.
2. Fazio VM, Rinaldi M, Ciafrè S, Barrera G and Farace MG: Control of neoplastic cell proliferation and differentiation by restoration of 4-hydroxynonenal physiological concentrations. Molec Aspects Med 14: 217-228, 1993.
3. Fazio VM, Barrera G, Muraca R, Rinaldi M, Ciafrè SA, Lazzari M, Dianzani MU and Farace MG: Differentiating agents and cancer therapy. Role of cellular lipid peroxidation and its product 4-hydroxynonenal in the control of cellular proliferation and differentiation. In: Combination Therapies 2 (Goldstein A.L. and Garaci E. eds). New York, Plenum Press, 1993, pp 105-114.
4. Barrera G, Di Mauro C, Muraca R, Ferrero D, Cavalli G, Fazio VM, Paradisi L and Dianzani MU: Induction of Differentiation in Human HL-60 Cells by 4-Hydroxynonenal, a Product of Lipid Peroxidation. Exp Cell Res 197; 148-152, 1991.
5. Fazio VM, Barrera G, Martinotti S, Farace MG, Giglioni B, Frati L, Manzari V and Dianzani MU: 4-hydroxy-nonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 cells. Cancer Res 52; 4866-4871, 1992.
6. Barrera G, Brossa O, Fazio VM, Farace MG, Paradisi L, Gravela E and Dianzani MU: Effects of 4-hydroxynonenal, a product of lipid peroxidation, on cell proliferation and ornithine decarboxylase activity. Free Rad Res Comms 14: 81-89, 1991.
7. Russel DH: Ornithine decarboxilase - a key regulatory enzyme in normal and neoplastic growth. Drug Metabolism Reviews 16: 1-88, 1988.
8. Gidlund M, Orn A, Patengale PK, Jansson M, Wigzell H and Nilsson K: Natural Killer cells kill tumor cells at a given stage of differentiation. Nature (Lond) 292; 848-850, 1981.
9. Stern P, Gidlund M, Orn A and Wigzell H: Natural killer cells mediate lysis of embryonal carcinoma cell lacking MHC. Nature (Lond) 285: 341-342, 1980.
10. Rinaldi M, Tricarico M, Bonmassar E, Parrella P, Barrera G and Fazio VM: Effect of 4-Hydroxynonenal, a product of lipid peroxidation, on NK susceptibility of human K562 target cells. Anticancer Res 18: 3591-3596, 1998.
11. Boyum A: Isolation of lymphocytes from human blood. Further observation. J Clin Lab Invest 21: 31-34, 1968.
12. Lozzio CB, Lozzio BB: Properties and usefulness of the original K562 human myelogenous leukemia cell line. Leuk Res 3: 363-369, 1979.
13. Abb J, Abb H and Deinhardt F: Effect of retinoic acid on the spontaneous and interferon-induced activity of human natural killer cells. Int J Cancer 30: 307-310, 1982.
14. Abb J, Abb H and Deinhardt F: Retinoic acid suppression of human leukocyte interferon production. Immunopharmacology 4: 303-310, 1982.
15. Malorni W, Straface E, Di Genova G, Fattorossi A, Rivabene R, Camponeschi B, Masella R and Viora M: Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network. Exp Cell Res 236: 436-445, 1997.
16. Lotzova E and Herberman RB: NK cell mediated cytotoxicity: Receptors, Signaling and Mechanism,CRC Press, Boca Raton, 1972, p 474, 1992.
17. Esterbauer H, Schaur RJ and Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 11: 81-128, 1991.
18. Dianzani MU: Lipid peroxidation and cancer. Crit Rev Oncol Hematol 15: 125-147, 1993.
19. Poli G, Dianzani MU, Cheeseman KH, Slater TF, Lang J and Esterbauer H: Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat liver hepatocytes and rat liver microsomal suspension. Biochem J 227: 629-638, 1985.
20. Esterbauer H, Gebicki J, Puhl H and Jurgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL: Free Rad Biol Med 13: 341-390, 1992.
21. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Sochr SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D and Witztum D: Low density lipoprotein undergoes oxidative modifications in vivo: Proc Natl Acad Sci USA 86: 1372-1376, 1989.
22. Leonarduzzi G, Scavazza A, Blasi F, Chiarpotto E, Camandola S, Vogl S, Dargel R, and Poli G: The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11: 851-857, 1997.
23. Bellone G, Aste-Amezaga M, Trinchieri G and Rodeck U: Regulation of NK cell function by TGF-β1. J Immunol 155: 1066-1073, 1995.